Baxter International (BAX) Shares Outstanding (Weighted Average) (2009 - 2026)
Baxter International (BAX) reported Shares Outstanding (Weighted Average) of $515.0 million for Q1 2026, up 0.59% year-over-year from $512.0 million in Q1 2025, and little changed quarter-over-quarter from $513.0 million in Q4 2025.
Baxter International (BAX) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $515.0 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $515.0 million, up 0.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $515.0 million (up 0.59% YoY), and the FY2025 annual result was $513.0 million, up 0.59% from the prior year.
- Shares Outstanding (Weighted Average) steadied at $515.0 million in Q1 2026 per BAX's latest filing, from $513.0 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $515.0 million in Q1 2026 and troughed at $503.0 million in Q1 2022.
- A 5-year average of $508.1 million and a median of $508.0 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) fell 0.4% in 2022, then grew 0.79% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $504.0 million in 2022, then increased by 0.4% to $506.0 million in 2023, then advanced by 0.79% to $510.0 million in 2024, then grew by 0.59% to $513.0 million in 2025, then climbed by 0.39% to $515.0 million in 2026.
- Business Quant data shows BAX's Shares Outstanding (Weighted Average) at $515.0 million in Q1 2026, $513.0 million in Q4 2025, and $513.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 354.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 283.14 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 819.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.34 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 174.20 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.43 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 64.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515.00 Mn |
| Dec 31, 2025 | 513.00 Mn |
| Sep 30, 2025 | 513.00 Mn |
| Jun 30, 2025 | 512.00 Mn |
| Mar 31, 2025 | 512.00 Mn |
| Dec 31, 2024 | 510.00 Mn |
| Sep 30, 2024 | 509.00 Mn |
| Jun 30, 2024 | 510.00 Mn |
| Mar 31, 2024 | 508.00 Mn |
| Dec 31, 2023 | 506.00 Mn |
| Sep 30, 2023 | 506.00 Mn |
| Jun 30, 2023 | 506.00 Mn |
| Mar 31, 2023 | 505.00 Mn |
| Dec 31, 2022 | 504.00 Mn |
| Sep 30, 2022 | 503.00 Mn |
| Jun 30, 2022 | 503.00 Mn |
| Mar 31, 2022 | 503.00 Mn |
| Dec 31, 2021 | 502.00 Mn |
| Sep 30, 2021 | 500.00 Mn |
| Jun 30, 2021 | 504.00 Mn |